19-1220434-G-C
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM1PM2PM5PP3_StrongPP5_Moderate
The NM_000455.5(STK11):c.526G>C(p.Asp176His) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 13/22 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D176A) has been classified as Uncertain significance.
Frequency
Consequence
NM_000455.5 missense
Scores
Clinical Significance
Conservation
Publications
- familial pancreatic carcinomaInheritance: AD Classification: DEFINITIVE Submitted by: G2P
- Peutz-Jeghers syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Orphanet, Genomics England PanelApp, G2P
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| STK11 | NM_000455.5 | c.526G>C | p.Asp176His | missense_variant | Exon 4 of 10 | ENST00000326873.12 | NP_000446.1 | |
| STK11 | NM_001407255.1 | c.526G>C | p.Asp176His | missense_variant | Exon 4 of 9 | NP_001394184.1 | ||
| STK11 | NR_176325.1 | n.1793G>C | non_coding_transcript_exon_variant | Exon 5 of 11 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| STK11 | ENST00000326873.12 | c.526G>C | p.Asp176His | missense_variant | Exon 4 of 10 | 1 | NM_000455.5 | ENSP00000324856.6 | ||
| STK11 | ENST00000652231.1 | c.526G>C | p.Asp176His | missense_variant | Exon 4 of 9 | ENSP00000498804.1 | ||||
| STK11 | ENST00000585748.3 | c.154G>C | p.Asp52His | missense_variant | Exon 6 of 12 | 3 | ENSP00000477641.2 | |||
| STK11 | ENST00000593219.6 | n.*351G>C | non_coding_transcript_exon_variant | Exon 5 of 11 | 3 | ENSP00000466610.1 | ||||
| STK11 | ENST00000593219.6 | n.*351G>C | 3_prime_UTR_variant | Exon 5 of 11 | 3 | ENSP00000466610.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.D176H variant (also known as c.526G>C), located in coding exon 4 of the STK11 gene, results from a G to C substitution at nucleotide position 526. The aspartic acid at codon 176 is replaced by histidine, an amino acid with similar properties. This variant was reported in individual(s) with features consistent with Peutz-Jeghers syndrome (Salloch H et al. Int J Colorectal Dis, 2010 Jan;25:97-107). Other variant(s) at the same codon, p.D176N (c.526G>A), have been identified in individual(s) with features consistent with Peutz-Jeghers syndrom (de Leng WW et al. Clin. Genet., 2007 Dec;72:568-73; Yang HR et al. Dig. Dis. Sci., 2010 Dec;55:3458-65; Wang Z et al. Hum. Mutat., 2014 Jul;35:851-8; Dai L et al. Dig. Dis. Sci., 2014 Aug;59:1856-61; Chiang JM et al. Asian J Surg, 2018 Sep;41:480-485). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Based on the majority of available evidence to date, this variant is likely to be pathogenic.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at